Secure Login

Please enter your user name and password below.
Forgot your password?
 
       •New User

Frequently Asked Questions
Related Content

New Drug Review 2014

This article reviews five new drugs (umeclidinium and vilanterol, vortioxetine, dapagliflozin, luliconazole, sofosbuvir) that were approved by the FDA in the past year.

Review of Selected NMEs 2014

Five new molecular entities (riociguat, ibrutinib, obinutuzumab, coagulation factor XIII A-subunit [recombinant], collagenase clostridium histolyticum) that were recently approved by the FDA are discussed.

The Off-Label Debate Rages On

Pharmacists who counsel patients should exercise caution and transparency in discussing a drug’s off-label uses until a specific court ruling is made.

AbbVie Acquires Shire in $54 Billion Deal



Black Is the New Gray in Pharmaceuticals

Certain medications are often sold outside of official channels.

View LessonContinuing Education
2.00Credit $6.50
Expires 12/31/2016

Clinical Management of Peptic Ulcer Disease



NEW RULES FOR CPE MONITOR REPORTING
Effective May 1, 2014 all ACPE-accredited providers have 60 days past the CPE activity participation date to upload the participant credit into CPE Monitor. Check the Frequently Asked Questions section for more details.

Page 1of 3 First Page |  Previous Page |  Next Page |  Last Page |  Reset Sort By: By Price  |  By Title
Page 1of 3 First Page |  Previous Page |  Next Page |  Last Page |  Reset Sort By: By Price  |  By Title